1-2 of 2
Jörg Westermann, MD PhD
Close
Sort by
Journal Articles

Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

Florian Kuchenbauer, MD PhD, Donald W. Bunjes, MD, Wolfgang Herr, MD, Michael Heuser, MD, Daniela Späth, MSc, Jochen Casper, MD, Heinz-August Horst, MD, Peter Brossart, MD, Gerhard Held, MD, Guido Kobbe, MD, Mark Ringhoffer, MD, Mohammed Wattad, MD, Helmut R Salih, MD, Katharina Götze, Gerald Wulf, MD, Matthias Theobald, MD PhD, Mathias J Rummel, MD, Walter Fiedler, MD, Jörg Westermann, MD PhD, Hans Salwender, MD, Andreas L. Petzer, MD, Frank Hartmann, MD, Michael Lübbert, Uwe Martens, MD, Richard Greil, MD, Hartmut H. Kirchner, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Felicitas Thol, MD, Gudrun Göhring, PD, Konstanze Döhner, MD, Arnold Ganser, Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2014) 124 (21): 1254.
https://doi.org/10.1182/blood.V124.21.1254.1254
Published: 2014
Journal Articles

Flow Cytometry-Based Maturity Score As a Novel Prognostic Parameter in AML

Anne Flörcken, MD, Schneider Tanja, MD, Anju Singh, MD, Seval Türkmen, MD, Burmeister Thomas, MD PhD, Joannis Anagnostopoulos, MD PhD, Antonio Pezzutto, MD PhD, Bernd Dörken, MD PhD, Jörg Westermann, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1006.
https://doi.org/10.1182/blood.V124.21.1006.1006
Published: 2014